La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Animals »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Animal Experimentation (standards) < Animals < Animals, Genetically Modified  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 547.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000000 (1999) S. Chalon [France] ; P. Emond ; S. Bodard ; M P Vilar ; C. Thiercelin ; J C Besnard ; D. GuilloteauTime course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease.
000022 (1999) B. Piallat [France] ; A. Benazzouz ; A L BenabidNeuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease.
000023 (1999) E. Bezard [France] ; T. Boraud ; B. Bioulac ; C E GrossInvolvement of the subthalamic nucleus in glutamatergic compensatory mechanisms.
000026 (1999) A M Bonnet [France] ; J L HouetoPathophysiology of Parkinson's disease.
000029 (1999) E C Hirsch [France]Mechanism and consequences of nerve cell death in Parkinson's disease.
000032 (1999) M P Muriel [France] ; V. Bernard ; A I Levey ; O. Laribi ; D N Abrous ; Yves Agid [France] ; B. Bloch ; E C HirschLevodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.
000033 (1999) O K Hassani [France] ; J. FégerEffects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
000037 (1999) P. Damier [France]New aspects in the pathophysiology of dyskinesia. Salpêtrière Deep Brain Stimulation Group.
000055 (1999) D. Guehl [France] ; E. Bezard ; S. Dovero ; T. Boraud ; B. Bioulac ; C. GrossTrichloroethylene and parkinsonism: a human and experimental observation.
000061 (1999) M. Vidailhet [France] ; A M Bonnet ; R. Marconi ; F. Durif ; Yves Agid [France]The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
000067 (1999) C E Gross [France] ; T. Boraud ; D. Guehl ; B. Bioulac ; E. BezardFrom experimentation to the surgical treatment of Parkinson's disease: prelude or suite in basal ganglia research?
000069 (1999) Olga Corti [France] ; Amelia Sánchez-Capelo [France] ; Philippe Colin [France] ; Naïma Hanoun [France] ; Michel Hamon [France] ; Jacques Mallet [France]Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson’s disease
000070 (1999) F. Torreilles [France] ; S. Salman-Tabcheh ; M. Guérin ; J. TorreillesNeurodegenerative disorders: the role of peroxynitrite.
000072 (1999) C. Fillebeen [France] ; V. Mitchell ; D. Dexter ; M. Benaissa ; J. Beauvillain ; G. Spik ; A. PierceLactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.
000079 (1999) E. Bezard [France] ; C. Brefel ; F. Tison ; H. Peyro-Saint-Paul ; P. Ladure ; O. Rascol ; C E GrossEffect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey.
000080 (1999) Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. TolosaLevodopa in the treatment of Parkinson's disease: a consensus meeting.
000084 (????) Yves Agid [France]Continuous high frequency stimulation of deep brain structures in brain pathology.
000088 (1999) V. Ben [France] ; O. Blin ; B. BruguerolleTime-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions.
000089 (2000) Andreas Hartmann [France] ; Stéphane Hunot [France] ; Patrick P. Michel [France] ; Marie-Paule Muriel [France] ; Sheela Vyas [Royaume-Uni] ; Baptiste A. Faucheux [France] ; Annick Mouatt-Prigent [France] ; Hélène Turmel [France] ; Anu Srinivasan [États-Unis] ; Merle Ruberg [France] ; Gerard I. Evan [Royaume-Uni] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
000090 (2000) I. Aubert [France] ; I. Ghorayeb ; E. Normand ; B. BlochPhenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
000091 (2000) T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E GrossEffects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Animals" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Animals" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Animals
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024